Divergent Effects of Endogenous and Exogenous Glucocorticoid‐Induced Leucine Zipper in Animal Models of Inflammation and Arthritis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective: Glucocorticoid‐induced leucine zipper (GILZ) has effects on inflammatory pathways that suggest it to be a key inhibitory regulator of the immune system, and its expression is exquisitely sensitive to induction by glucocorticoids. We undertook this study to test our hypothesis that GILZ deficiency would exacerbate experimental immune‐mediated inflammation and impair the effects of glucocorticoids on inflammation and, correspondingly, that exogenous GILZ would inhibit these events. Methods: GILZ−/− mice were generated using the Cre/loxP system, and responses were studied in delayed‐type hypersensitivity (DTH), antigen‐induced arthritis (AIA), K/BxN serum–transfer arthritis, and lipopolysaccharide (LPS)–induced cytokinemia. Therapeutic expression of GILZ via administration of recombinant adeno‐associated virus expressing the GILZ gene (GILZ‐rAAV) was compared to the effects of glucocorticoid in collagen‐induced arthritis (CIA). Results: Increased T cell proliferation and DTH were observed in GILZ−/− mice, but neither AIA nor K/BxN serum–transfer arthritis was affected, and GILZ deficiency did not affect LPS‐induced cytokinemia. Deletion of GILZ did not impair the effects of exogenous glucocorticoids on CIA or cytokinemia. In contrast, overexpression of GILZ in joints significantly inhibited CIA, with an effect similar to that of dexamethasone. Conclusion: Despite effects on T cell activation, GILZ deficiency had no effect on effector pathways of arthritis and was unexpectedly redundant with effects of glucocorticoids. These findings do not support the hypothesis that GILZ is central to the actions of glucocorticoids, but the efficacy of exogenous GILZ in CIA suggests that further evaluation of GILZ in inflammatory disease is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068 · cited 1×
“Since the discovery that dimerization of the GR is not required for inhibition of the NF- B and AP-1 pathways (28), transrepression has been considered the dominant means through which glucocorticoids regulate Figure 4.”
BackgroundDose-related patterns of glucocorticoid-induced side effects
Huscher, D., Thiele, K., Gromnica-Ihle, E., Hein, G., Demary, W., Dreher, R., Zink, A., & Buttgereit, F. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092163 · Cited by 604
Surjit, M., Ganti, K. P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Li, M., & Chambon, P. (2011) · Cell · doi:10.1016/j.cell.2011.03.027 · Cited by 551 · cited 1×
“repression of gene expression (42) is unknown.”
D'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., Cannarile, L., Migliorati, G., & Riccardi, C. (1997) · Immunity · doi:10.1016/s1074-7613(00)80398-2 · Cited by 444
Hammer, M., Mages, J., Dietrich, H., Servatius, A., Howells, N., Cato, A. C. B., & Lang, R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051753 · Cited by 327 · cited 2×
“It has not previously been established whether endogenous GILZ is required for the effects of glucocorticoids or whether it acts as a constitutive inhibitory regulator of the immune response like other glucocorticoid-induced antiinflammatory proteins (31,32).”
BackgroundKleiman, A., Hübner, S., Parkitna, J. M. R., Neumann, A., Hofer, S., Weigand, M. A., Bauer, M., Schmid, W., Schütz, G., Libert, C., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-192112 · Cited by 152
Chinenov, Y., & Rogatsky, I. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.014 · Cited by 133
Xin, K.-Q., Mizukami, H., Urabe, M., Toda, Y., Shinoda, K., Yoshida, A., Oomura, K., Kojima, Y., Ichino, M., Klinman, D., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00890-06 · Cited by 81 · cited 1×
“AAV serotype 5 has been shown to have tropism for dendritic cells, synovial fibroblasts, and endothelial cells in vitro, and to successfully deliver genes to the inflamed joint in vivo (23,39).”
Background
Cited by
Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity
Yang, H., Xia, L., Chen, J., Zhang, S., Martin, V., Li, Q., Lin, S., Chen, J., Calmette, J., Lu, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0566-4 · Cited by 379
Self-citationLibert, C., & Dejager, L. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.041 · Cited by 69
Eiers, A.-K., Vettorazzi, S., & Tuckermann, J. P. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-225371 · Cited by 31
“61 Furthermore, evidence emerged that GC-induced genes with anti-inflammatory effects are essentially contributing to anti-inflammatory actions by GCs, such as Dusp1 (dual specificity phosphatase 1), 62 Anxa1, 63 Gilz (glucocorticoid-induced leucine zipper) 64 and A20.”
Metadata
- Authors
- Ngo, D., Beaulieu, E., Gu, R., Leaney, A., Santos, L., Fan, H., Yang, Y., Kao, W., Xu, J., Escriou, V., Loiler, S., Vervoordeldonk, M. J., & Morand, E. F.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2013-04-23
- Volume
- 65
- Issue
- 5
- Pages
- 1203-1212
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2081005510
- Cited by
- 61
- References
- 8
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.